BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26209639)

  • 1. Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.
    Mar AC; Chu CH; Lee HJ; Chien CW; Cheng JJ; Yang SH; Jiang JK; Lee TC
    J Biol Chem; 2015 Sep; 290(36):22212-24. PubMed ID: 26209639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of interleukin-1 receptor type II enhances cell migration through activation of the pre-interleukin 1alpha pathway.
    Chang SY; Su PF; Lee TC
    Cytokine; 2009 Jan; 45(1):32-8. PubMed ID: 19026558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer.
    Lee Y; Kim SJ; Choo J; Heo G; Yoo JW; Jung Y; Rhee SH; Im E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.
    Kim TH; Hur EG; Kang SJ; Kim JA; Thapa D; Lee YM; Ku SK; Jung Y; Kwak MK
    Cancer Res; 2011 Mar; 71(6):2260-75. PubMed ID: 21278237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells.
    Jeong E; Koo JE; Yeon SH; Kwak MK; Hwang DH; Lee JY
    Mol Carcinog; 2014 Nov; 53(11):926-37. PubMed ID: 24610641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.
    Lau WH; Pandey V; Kong X; Wang XN; Wu Z; Zhu T; Lobie PE
    PLoS One; 2015; 10(11):e0141947. PubMed ID: 26559818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer.
    Xing X; Gu X; Ma T; Ye H
    Tumour Biol; 2015 Mar; 36(3):1773-80. PubMed ID: 25371074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism.
    Ahluwalia A; Jones MK; Szabo S; Tarnawski AS
    Biochem Biophys Res Commun; 2013 Aug; 437(4):515-20. PubMed ID: 23831629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Zhu D; Sun Y; Zhang D; Dong M; Jiang G; Zhang X; Zhou J
    Oncol Rep; 2018 Aug; 40(2):589-598. PubMed ID: 29845255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
    Liang H; Zhong Y; Zhou S; Peng L
    Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.
    Nagasaki T; Hara M; Nakanishi H; Takahashi H; Sato M; Takeyama H
    Br J Cancer; 2014 Jan; 110(2):469-78. PubMed ID: 24346288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.
    Tzeng HE; Tsai CH; Chang ZL; Su CM; Wang SW; Hwang WL; Tang CH
    Biochem Pharmacol; 2013 Feb; 85(4):531-40. PubMed ID: 23219526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.
    Hamdollah Zadeh MA; Amin EM; Hoareau-Aveilla C; Domingo E; Symonds KE; Ye X; Heesom KJ; Salmon A; D'Silva O; Betteridge KB; Williams AC; Kerr DJ; Salmon AH; Oltean S; Midgley RS; Ladomery MR; Harper SJ; Varey AH; Bates DO
    Mol Oncol; 2015 Jan; 9(1):167-78. PubMed ID: 25224594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
    Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
    Fang Y; Sun B; Wang J; Wang Y
    Gene; 2019 May; 699():37-42. PubMed ID: 30851425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
    Li X; Wang X; Li Z; Zhang Z; Zhang Y
    Cancer Med; 2019 Sep; 8(11):5327-5340. PubMed ID: 31348616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.